4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-043062
Director sold 1,666 shares at an average $70.74 ($117,845)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2021-06-23 | Sale | −680 | $70.20 | $47,735 | 135,483 | D |
| SATO VICKI L Director | 2021-06-23 | Sale | −986 | $71.11 | $70,110 | 134,497 | D |
| Open-market sales · 1,666 sh · avg $70.74 · $117,845 | |||||||
Loading xslF345X03/doc4.xml…